These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
624 related articles for article (PubMed ID: 11956072)
21. Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis. Witkiewicz AK; Varambally S; Shen R; Mehra R; Sabel MS; Ghosh D; Chinnaiyan AM; Rubin MA; Kleer CG Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1418-23. PubMed ID: 15941950 [TBL] [Abstract][Full Text] [Related]
22. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer. Zhou M; Jiang Z; Epstein JI Am J Surg Pathol; 2003 Jun; 27(6):772-8. PubMed ID: 12766580 [TBL] [Abstract][Full Text] [Related]
23. [Detection of AMACR (P504S), P63 and 34betaE12 cocktail in the early diagnosis of prostate cancer]. Yu T; Zhu SX; Zheng S; Chen SP Zhonghua Nan Ke Xue; 2007 Mar; 13(3):222-5. PubMed ID: 17393784 [TBL] [Abstract][Full Text] [Related]
24. Expression profiling identifies a novel alpha-methylacyl-CoA racemase exon with fumarate hydratase homology. Shen-Ong GL; Feng Y; Troyer DA Cancer Res; 2003 Jun; 63(12):3296-301. PubMed ID: 12810662 [TBL] [Abstract][Full Text] [Related]
25. Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer. Kunju LP; Chinnaiyan AM; Shah RB Histopathology; 2005 Dec; 47(6):587-96. PubMed ID: 16324196 [TBL] [Abstract][Full Text] [Related]
26. Alternative spliced variants of the alpha-methylacyl-CoA racemase gene and their expression in prostate cancer. Mubiru JN; Shen-Ong GL; Valente AJ; Troyer DA Gene; 2004 Feb; 327(1):89-98. PubMed ID: 14960364 [TBL] [Abstract][Full Text] [Related]
27. Usefulness of cytokeratin 5/6 and AMACR applied as double sequential immunostains for diagnostic assessment of problematic prostate specimens. Trpkov K; Bartczak-McKay J; Yilmaz A Am J Clin Pathol; 2009 Aug; 132(2):211-20; quiz 307. PubMed ID: 19605815 [TBL] [Abstract][Full Text] [Related]
28. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells. Weinstein MH; Signoretti S; Loda M Mod Pathol; 2002 Dec; 15(12):1302-8. PubMed ID: 12481011 [TBL] [Abstract][Full Text] [Related]
29. Conversion of prostate cancer from hormone independency to dependency due to AMACR inhibition: involvement of increased AR expression and decreased IGF1 expression. Takahara K; Azuma H; Sakamoto T; Kiyama S; Inamoto T; Ibuki N; Nishida T; Nomi H; Ubai T; Segawa N; Katsuoka Y Anticancer Res; 2009 Jul; 29(7):2497-505. PubMed ID: 19596919 [TBL] [Abstract][Full Text] [Related]
30. A variant of the alpha-methyl-acyl-CoA racemase gene created by a deletion in exon 5 and its expression in prostate cancer. Mubiru JN; Valente AJ; Troyer DA Prostate; 2005 Oct; 65(2):117-23. PubMed ID: 15880524 [TBL] [Abstract][Full Text] [Related]
31. Abundant expression of AMACR in many distinct tumour types. Went PT; Sauter G; Oberholzer M; Bubendorf L Pathology; 2006 Oct; 38(5):426-32. PubMed ID: 17008281 [TBL] [Abstract][Full Text] [Related]
32. Peroxisomal branched chain fatty acid beta-oxidation pathway is upregulated in prostate cancer. Zha S; Ferdinandusse S; Hicks JL; Denis S; Dunn TA; Wanders RJ; Luo J; De Marzo AM; Isaacs WB Prostate; 2005 Jun; 63(4):316-23. PubMed ID: 15599942 [TBL] [Abstract][Full Text] [Related]
33. Altered expression of alpha-methylacyl-coenzyme A racemase in prostatic adenocarcinoma following hormone therapy. Suzue K; Montag AG; Tretiakova M; Yang XJ; Sahoo S Am J Clin Pathol; 2005 Apr; 123(4):553-61. PubMed ID: 15743746 [TBL] [Abstract][Full Text] [Related]
34. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. Rubin MA; Zhou M; Dhanasekaran SM; Varambally S; Barrette TR; Sanda MG; Pienta KJ; Ghosh D; Chinnaiyan AM JAMA; 2002 Apr; 287(13):1662-70. PubMed ID: 11926890 [TBL] [Abstract][Full Text] [Related]
36. Alpha-methylacyl coenzyme A racemase immunoreactivity in partial atrophy of the prostate. Adley BP; Yang XJ Am J Clin Pathol; 2006 Dec; 126(6):849-55. PubMed ID: 17074684 [TBL] [Abstract][Full Text] [Related]
37. Reliability of the 34βE12, keratin 5/6, p63, bcl-2, and AMACR in the diagnosis of prostate carcinoma. Boran C; Kandirali E; Yilmaz F; Serin E; Akyol M Urol Oncol; 2011; 29(6):614-23. PubMed ID: 20189848 [TBL] [Abstract][Full Text] [Related]
38. Is triple immunostaining with 34betaE12, p63, and racemase in prostate cancer advantageous? A tissue microarray study. Ng VW; Koh M; Tan SY; Tan PH Am J Clin Pathol; 2007 Feb; 127(2):248-53. PubMed ID: 17210521 [TBL] [Abstract][Full Text] [Related]
39. Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy. Magi-Galluzzi C; Luo J; Isaacs WB; Hicks JL; de Marzo AM; Epstein JI Am J Surg Pathol; 2003 Aug; 27(8):1128-33. PubMed ID: 12883245 [TBL] [Abstract][Full Text] [Related]
40. Variation of alpha-methylacyl-CoA racemase expression in prostate adenocarcinoma cases receiving hormonal therapy. Tang X; Serizawa A; Tokunaga M; Yasuda M; Matsushita K; Terachi T; Osamura RY Hum Pathol; 2006 Sep; 37(9):1186-92. PubMed ID: 16938524 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]